Results 301 to 310 of about 377,962 (403)

Identifying prognostic targets in metastatic prostate cancer beyond AR

FEBS Open Bio, EarlyView.
Genome‐wide functional screens combined with a large gene expression database and clinical outcomes can identify new therapeutic vulnerabilities in prostate cancer. Eight potentially druggable targets demonstrated strong dependency in cell lines, were associated with worse prognosis clinically, and showed evidence of protein expression in prostate ...
Emily Feng, Eric Feng, Tracy Berg, Isabella S. Nguyen, Lilac G. Nguyen, William Chen, Meng Zhang, David Quigley, Marina Sharifi, Haolong Li, Ilsa Coleman, Peter S. Nelson, Martin Sjöström, Shuang G. Zhao   +13 more
wiley   +1 more source

Challenges and Opportunities in Delivering and Providing Culturally and Linguistically Tailored Cardiovascular Disease and Stroke Prevention Education: A Qualitative Exploratory Study. [PDF]

Health Expect
Allida SM, Maneze D, William S, Hackett M, Ferguson C.   +4 more
europepmc   +1 more source

Current trends in single‐cell RNA sequencing applications in diabetes mellitus

FEBS Open Bio, EarlyView.
Single‐cell RNA sequencing is a powerful approach to decipher the cellular and molecular landscape at a single‐cell resolution. The rapid development of this technology has led to a wide range of applications, including the detection of cellular and molecular mechanisms and the identification and introduction of novel potential diagnostic and ...
Seyed Sajjad Zadian, Khodakaram Jahanbin, Shekoofeh Nikooei, Marzieh Rostaminejad, Arezoo Rahimi, Pedram Abdizadeh, Behnam Alipoor   +6 more
wiley   +1 more source

Quality of Serious Illness Communication with Hospitalized Limited English Proficient Patients: A Mixed Methods Study. [PDF]

Palliat Med Rep
Holdsworth LM, Kling SMR, Winget M, Mui HZ, Garvert DW, Veruttipong D, Seevaratnam B, Harris S, Teuteberg W.   +8 more
europepmc   +1 more source

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor‐adapted non‐small cell lung cancer cell lines

FEBS Open Bio, EarlyView.
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash, Campbell W. Gourlay, Ina Oehme, Michelle D. Garrett, Jindrich Cinatl Jr, Mark N. Wass, Martin Michaelis   +6 more
wiley   +1 more source

Trends in Language Assistance for Adults With Non-English Language Preference in California.

JAMA Netw Open
Linares M, Rodriguez JA, Samal L.
europepmc   +1 more source

Understanding a Minority Group's (Roma) Experiences of Access and Quality in Maternity Services. [PDF]

Health Expect
Dullat JK, McDonnell T, Hendrick L, McMahon L, Moore G, Murphy E, Nae C, Nae D, Prontera M, McAuliffe E.   +9 more
europepmc   +1 more source

The E3 ubiquitin ligase, RNF219, suppresses CNOT6L expression to exhibit antiproliferative activity

FEBS Open Bio, EarlyView.
We identified RNF219 as a CCR4‐NOT complex‐interacting E3 ubiquitin ligase that targets the CCR4‐NOT subunit CNOT6L for ubiquitination. RNF219 directly binds to the DUF3819 domain of CNOT1 through its putative α‐helix spanning amino acids 521–542. Our findings also suggest that antiproliferative activity of RNF219 is at least partially mediated by ...
Shou Soeda, Melissa Montrose, Akinori Takahashi, Risa Ishida, Sandrine Burriel, Nao Ohmine, Tohru Natsume, Shungo Adachi, Minsoo Kim, Tadashi Yamamoto   +9 more
wiley   +1 more source

Improving Ethnic Diversity in Cancer Trials Through Healthcare Interpreter Training. [PDF]

Cancer Med
Grant SJ, Ouriques M, Pal A, Lee S, Challam S, Jasicki L.   +5 more
europepmc   +1 more source